This evidence, which supports an essential role for angiogenic factors in intestinal IRI, suggests that both the VEGF/eNOS pathway and CD34 modulation are required for efficient vascular endothelial differentiation, giving reasonable use of KYP-2047 in attenuation of vascular alterations in intestinal diseases. This evidence concerns the gene VEGFA and intestinal disorder.